HC Wainwright Predicts Stronger Earnings for Scholar Rock

Scholar Rock Holding Co. (NASDAQ:SRRK) – Equities research analysts at HC Wainwright increased their FY2026 earnings per share estimates for shares of Scholar Rock in a report issued on Tuesday, November 26th. HC Wainwright analyst A. Maldonado now expects that the company will earn ($1.57) per share for the year, up from their previous estimate of ($1.68). HC Wainwright currently has a “Buy” rating and a $50.00 target price on the stock. The consensus estimate for Scholar Rock’s current full-year earnings is ($2.40) per share. HC Wainwright also issued estimates for Scholar Rock’s FY2027 earnings at ($0.78) EPS and FY2028 earnings at $0.18 EPS.

A number of other brokerages have also recently commented on SRRK. BMO Capital Markets upped their price target on shares of Scholar Rock from $34.00 to $38.00 and gave the company an “outperform” rating in a research note on Friday, October 11th. JPMorgan Chase & Co. increased their target price on Scholar Rock from $18.00 to $31.00 and gave the stock an “overweight” rating in a research report on Monday, October 14th. Piper Sandler raised their price target on Scholar Rock from $28.00 to $42.00 and gave the stock an “overweight” rating in a report on Tuesday, October 15th. Wedbush boosted their price objective on Scholar Rock from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday. Finally, Truist Financial raised their target price on Scholar Rock from $36.00 to $45.00 and gave the stock a “buy” rating in a research note on Monday. Six analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $40.43.

Scholar Rock Price Performance

NASDAQ SRRK opened at $38.15 on Thursday. The company has a quick ratio of 3.88, a current ratio of 3.88 and a debt-to-equity ratio of 0.63. The company has a market cap of $3.57 billion, a PE ratio of -16.23 and a beta of 0.47. Scholar Rock has a 52 week low of $6.76 and a 52 week high of $43.38. The firm’s 50-day simple moving average is $24.29 and its two-hundred day simple moving average is $14.54.

Insider Activity

In related news, major shareholder Public Equities L.P. Invus sold 409,433 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $38.49, for a total value of $15,759,076.17. Following the sale, the insider now directly owns 10,850,005 shares of the company’s stock, valued at $417,616,692.45. This trade represents a 3.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Edward H. Myles sold 206,240 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $26.56, for a total transaction of $5,477,734.40. Following the completion of the transaction, the chief financial officer now directly owns 161,088 shares of the company’s stock, valued at approximately $4,278,497.28. This represents a 56.15 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,823,322 shares of company stock worth $56,411,627 in the last three months. Corporate insiders own 19.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. FMR LLC boosted its holdings in shares of Scholar Rock by 3.1% in the 3rd quarter. FMR LLC now owns 10,196,046 shares of the company’s stock worth $81,670,000 after purchasing an additional 308,813 shares in the last quarter. Vanguard Group Inc. lifted its position in Scholar Rock by 4.0% in the 1st quarter. Vanguard Group Inc. now owns 2,969,534 shares of the company’s stock worth $52,739,000 after buying an additional 114,550 shares during the last quarter. Geode Capital Management LLC boosted its stake in Scholar Rock by 8.5% in the third quarter. Geode Capital Management LLC now owns 1,543,025 shares of the company’s stock worth $12,361,000 after buying an additional 120,489 shares in the last quarter. Millennium Management LLC grew its position in Scholar Rock by 159.2% during the second quarter. Millennium Management LLC now owns 925,584 shares of the company’s stock valued at $7,710,000 after acquiring an additional 568,512 shares during the last quarter. Finally, Hood River Capital Management LLC raised its stake in shares of Scholar Rock by 5.1% during the second quarter. Hood River Capital Management LLC now owns 832,792 shares of the company’s stock worth $6,937,000 after acquiring an additional 40,745 shares in the last quarter. Institutional investors own 91.08% of the company’s stock.

About Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.